# Hizentra

NDC: 44206-452
Generic name: HUMAN IMMUNOGLOBULIN G
Labeler / Manufacturer: CSL Behring AG
Product type: PLASMA DERIVATIVE
Marketing category: Biologic License Application
Dosage form: LIQUID
Routes: SUBCUTANEOUS
Marketing started: 20111003

FDA application: BLA125350

## Active ingredients

- HUMAN IMMUNOGLOBULIN G: .2 g/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"44206-452"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=44206-452